| IL10 | 100 | 93 | 99 | 110 | 114 | 114 | 119 | ||||
| LAG3 | 100 | 82 | 102 | 109 | 110 | 106 | 106 | ||||
| CD19 | 100 | 82 | 104 | 114 | 114 | 106 | 124 | CD19 decreased 16% Day 5; increased 24% Day 730 | |||
| DEFB127 | 100 | 102 | 83 | 102 | 106 | 118 | 126 | ||||
| IL12A | 100 | 125 | 105 | 116 | 116 | 119 | 181 | IL12A increased 25% Day 5; increased 81% Day 730 | |||
| NFKB1 | 100 | 77 | 103 | 101 | 104 | 80 | 111 | NFKB1 decreased 23% Day 5 | |||
| CD4 | 100 | 79 | 105 | 95 | 112 | 103 | 114 | CD4 decreased 21% Day 5 | |||
| EGF | 100 | 115 | 100 | 120 | 123 | 131 | 159 | EGF increased Days 5 - 730 to 59% | |||
| IL12B | 100 | 81 | 98 | 115 | 116 | 115 | 130 | IL12B decreased 19% Day 5 | |||
| PDCD1 | 100 | 82 | 106 | 106 | 108 | 107 | 100 | PDCD1 decreased 18% Day 5 | |||
| CD40 | 100 | 126 | 101 | 117 | 123 | 101 | 148 | CD40 increased 26% Day 5; increased 48% Day 730 | |||
| GAPDH | 100 | 160 | 102 | 123 | 124 | 136 | 156 | GAPDH increased 60% Day 5; 56% Day 730 | |||
| IL18 | 100 | 96 | 100 | 113 | 114 | 113 | 121 | ||||
| TGFA | 100 | 84 | 106 | 106 | 102 | 99 | 107 | TGFA decreased 16% Day 5 | |||
| CD8A | 100 | 91 | 97 | 103 | 101 | 111 | 81 | ||||
| HBD | 100 | 121 | 93 | 114 | 119 | 120 | 147 | HBD increased 21% Day 5 to 47% Day 730 | |||
| IL2 | 100 | 85 | 101 | 108 | 110 | 106 | 121 | IL2 decreased 15% Day 5 and increased 21% Day 730 | |||
| CD8B | 100 | 76 | 105 | 110 | 106 | 112 | 117 | CD8B decreased 24% Day 5 | |||
| IFNA1 | 100 | 104 | 105 | 126 | 126 | 139 | 168 | IFNA1 increased gradually to 68% Day 730 | |||
| IL4 | 100 | 53 | 121 | 99 | 110 | 98 | 99 | IL4 < 47% Day 5; then >68% Day 10 relative to Day 5 | |||
| DEFA1 | 100 | 110 | 103 | 123 | 140 | 138 | 184 | DEFA1 increased from Day 5 to 84% Day 730 | |||
| IFNB1 | 100 | 98 | 104 | 125 | 125 | 126 | 126 | ||||
| IL5 | 100 | 84 | 91 | 107 | 108 | 108 | 134 | ||||